GLP-1 NAION Lawsuit MDL 3163: Case Management Orders (CMOs)
Track the latest legal updates, scheduling protocols, and Case Management Orders (CMOs) in MDL 3163: In Re: GLP-1 Receptor Agonists NAION Products Liability Litigation. Bookmark this page for a chronological log of court filings regarding Ozempic and Wegovy vision loss claims.
Ozempic Lawsuit MDL 3094 Case Management Orders (CMOs)
Ozempic litigation MDL 3094 case management orders (CMOs) – stay current on the latest updates related to the Ozempic lawsuits in MDL 3094.
The Ozempic Lawsuit: What it Could Mean for Rybelsus, Wegovy and Trulicity
The Ozempic Lawsuit, officially known as MDL 3094 IN RE: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION, was formed on February 2, 2024 in the Eastern District of Pennsylvania. The Judge assigned to the litigation is Judge Gene E. K. Pratter. The lawsuit alleges that the manufacturers failed to warn consumers about the […]
The Latest Information on the Ozempic Lawsuit: March and April Update
Ozempic lawsuit developments in March and April of 2024.
